Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
2.830
-0.090 (-3.08%)
Nov 13, 2026, 3:04 PM CST

SHE:300267 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,1061,1661,1401,7831,8712,235
Revenue Growth
-14.42%2.30%-36.09%-4.67%-16.32%-6.17%
Gross Profit
275.44261.03289.86281.73410.79319.44
Operating Income
5.3-34.83-90.18-183.08-10.65-150.49
Net Income
-346.97-379.82-373.37-195.3245.94-791.2
Earnings Per Share
-0.17-0.18-0.18-0.090.02-0.38
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Industry
919.261,1071,7331,7842,221
New Energy Industry
213.289.9930.11--
Others
33.2222.3119.7986.1714.08
Total
1,1661,1401,7831,8712,235

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
960987.4818.54744.47878.79761.56
Total Debt
702.4588.03509.27345.21403.33252.04
Net Cash (Debt)
257.6399.38309.27399.25475.46509.53
Net Cash Growth
-7.55%29.13%-22.54%-16.03%-6.69%-38.28%
Net Cash Per Share
0.120.190.150.190.230.25

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
71.67257.68166.69148.42281.0292.68
Capital Expenditures
-237.03-163.98-195.6-238.19-173.49-349.33
Free Cash Flow
-165.3693.7-28.91-89.77107.53-256.65
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
24.92%22.39%25.44%15.80%21.96%14.29%
Operating Margin
0.48%-2.99%-7.91%-10.27%-0.57%-6.73%
Pretax Margin
-29.84%-31.55%-34.06%-11.16%0.93%-37.84%
Profit Margin
-31.39%-32.58%-32.76%-10.95%2.46%-35.40%
FCF Margin
-14.96%8.04%-2.54%-5.03%5.75%-11.48%

Dividends

Fiscal Year
FY 2022
Period EndingJan '23
Dividend Per Share
0.030
Dividend Per Share Growth
-
Dividend Yield
0.84%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
----159.37-
Forward PE
-38.5438.5438.5438.5438.54
P/FCF Ratio
-75.06--68.10-
PS Ratio
5.286.035.033.713.924.37